The differential effects of donepezil and placebo on EEG/ ERP measures and fMRI in mild cognitive impairment and elderly controls.

Trial Profile

The differential effects of donepezil and placebo on EEG/ ERP measures and fMRI in mild cognitive impairment and elderly controls.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Donepezil (Primary)
  • Indications Amnesia; Mild cognitive impairment
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2012 Company added in the association field as reported by EudraCT.
    • 31 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top